Fitxers
Embargament
Document embargat fins el 2028-05-01Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/231146
Quality-by-design as the pharmaceutical innovation paradigm: mapping the field and proposing a conceptual framework
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Quality management (QM) and innovation practices are essential for business competitiveness, yet they often conflict when striving for radical advancements within complex innovation ecosystems. Amid this debate, the concept of Quality-by-Design (QbD) remains underexplored in management literature, despite its extensive development in technical fields. Taking the case of QbD in the pharmaceutical sector, this study aims at researching into its relationship with innovation, considering the interactions within the innovation ecosystem. We perform a bibliometric study, a selective content analysis combined with an assessment of the regulatory framework and relevant examples from the industry.
Matèries (anglès)
Citació
Col·leccions
Citació
HERNÁNDEZ VIVANCO, Alfonso Antonio, et al. Quality-by-design as the pharmaceutical innovation paradigm: mapping the field and proposing a conceptual framework. Technological Forecasting and Social Change. 2025. Vol. 217. ISSN 0040-1625. [consulted: 19 of August of 2026]. Available at: https://hdl.handle.net/2445/231146